Previous Close | 142.39 |
Open | 142.54 |
Bid | 0.00 x 800 |
Ask | 0.00 x 1000 |
Day's Range | 142.28 - 144.10 |
52 Week Range | 130.96 - 168.11 |
Volume | |
Avg. Volume | 4,903,798 |
Market Cap | 253.196B |
Beta (5Y Monthly) | 0.48 |
PE Ratio (TTM) | 39.18 |
EPS (TTM) | 3.66 |
Earnings Date | Feb 07, 2024 - Feb 12, 2024 |
Forward Dividend & Yield | 6.20 (4.32%) |
Ex-Dividend Date | Jan 12, 2024 |
1y Target Est | 169.72 |
Over long periods, dividend stocks tend to outperform their non-dividend-paying counterparts. There are likely several reasons for this, one of which is that sustaining a dividend program requires a solid underlying business. It's a Dividend King with 52 consecutive years of payout hikes -- if you include the time it spent as a unit of Abbott Laboratories.
The S&P 500 is the benchmark for the investing world. Dividend investors are a large group with a specific investing strategy, buying stocks that will help them build large income streams from dividends. American tobacco giant Altria Group (NYSE: MO) has made millions for shareholders over the past century selling Marlboro cigarettes in the United States.
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q3 2023 Earnings Call Transcript November 29, 2023 CollPlant Biotechnologies Ltd. misses on earnings expectations. Reported EPS is $-0.38 EPS, expectations were $-0.13. Operator: Greetings. And welcome to the CollPlant Biotechnologies Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like […]